Direct-to-Consumer Platforms for New Antiobesity Medications - Concerns and Potential Opportunities. Golovaty I, Hagan S. N Engl J Med 2024;390:677-680.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Golovaty I, Hagan S. Direct-to-Consumer Platforms for New Antiobesity Medications - Concerns and Potential Opportunities. N Engl J Med 2024;390:677-680.
PMID: 38375888